Åsa Petersén

91 – 100 of 122

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/person/75c7b528-610f-40ec-b44c-4f6d8766f219?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
…
9
10
11
12
13
next »

2007
Mark Reduced orexin levels in the cerebrospinal fluid of suicidal patients with major depressive disorder.
Brundin, Lena ^LU ; Björkqvist, Maria ^LU ; Petersén, Åsa ^LU and Träskman Bendz, Lil ^LU (2007) In European Neuropsychopharmacology 17(Mar 6). p.573-579
- Contribution to journal › Article
Mark Orexin and psychiatric symptoms in suicide attempters.
Brundin, Lena ^LU ; Petersén, Åsa ^LU ; Björkqvist, Maria ^LU and Träskman Bendz, Lil ^LU (2007) In Journal of Affective Disorders 100(1-3). p.259-263
- Contribution to journal › Article
2006
Mark Progressive alterations in the hypothalamic-pituitary-adrenal axis in the R6/2 transgenic mouse model of Huntington's disease
Björkqvist, Maria ^LU ; Petersén, Åsa ^LU ; Bacos, Karl ^LU ; Isaacs, J ; Norlén, Per ^LU ; Gil, Joana ; Popovic, Natalija ; Sundler, Frank ^LU ; Bates, GP and Tabrizi, SJ , et al. (2006) In Human Molecular Genetics 15(10). p.1713-1721
- Contribution to journal › Article
Mark Normal sensitivity to excitotoxicity in a transgenic Huntington's disease rat
Winkler, C ; Gil, Joana ^LU ; Araujo, Ines ^LU ; Riess, O ; Skripuletz, T ; Horsten, S and Petersén, Åsa ^LU (2006) In Brain Research Bulletin 69(3). p.306-310
- Contribution to journal › Article
Mark Hypothalamic-endocrine aspects in Huntington's disease.
Petersén, Åsa ^LU and Björkqvist, Maria ^LU (2006) In European Journal of Neuroscience 24(4). p.961-967
- Contribution to journal › Scientific review
Mark Laminin {alpha}1 chain improves laminin {alpha}2 chain deficient peripheral neuropathy.
Gawlik, Kinga ^LU ; Li, Jia-Yi ^LU ; Petersén, Åsa ^LU and Durbeej-Hjalt, Madeleine ^LU (2006) In Human Molecular Genetics 15(18). p.2690-2700
- Contribution to journal › Article
Mark Cerebrospinal fluid levels of orexin-A are not a clinically useful biomarker for Huntington disease.
Björkqvist, Maria ^LU ; Petersén, Åsa ^LU ; Nielsen, J ; Ecker, D ; Mulder, Hindrik ^LU ; Hayden, Mr ; Landwehrmeyer, B ; Brundin, Patrik ^LU and Leavitt, Br (2006) In Clinical Genetics 70(1). p.78-79
- Contribution to journal › Letter
2005
Mark The R6/2 transgenic mouse model of Huntington's disease develops diabetes due to deficient {beta}-cell mass and exocytosis.
Björkqvist, Maria ^LU ; Fex, Malin ^LU ; Renström, Erik ^LU ; Wierup, Nils ^LU ; Petersén, Åsa ^LU ; Gil, Joana ^LU ; Bacos, Karl ^LU ; Popovic, Natalija ^LU ; Li, Jia-Yi ^LU and Sundler, Frank ^LU , et al. (2005) In Human Molecular Genetics 14(5). p.565-574
- Contribution to journal › Article
Mark Orexin loss in Huntington's disease.
Petersén, Åsa ^LU ; Gil, Joana ^LU ; Maat-Schieman, Marion L C ; Björkqvist, Maria ^LU ; Tanila, Heikki ; Araújo, Ines M ; Smith, Ruben ^LU ; Popovic, Natalija ^LU ; Wierup, Nils ^LU and Norlén, Per ^LU , et al. (2005) In Human Molecular Genetics 14(1). p.39-47
- Contribution to journal › Article
Mark Reduced hippocampal neurogenesis in R6/2 transgenic Huntington's disease mice.
Gil, Joana ^LU ; Mohapel, Paul ^LU ; Araujo, Ines ^LU ; Popovic, Natalija ^LU ; Li, Jia-Yi ^LU ; Brundin, Patrik ^LU and Petersén, Åsa ^LU (2005) In Neurobiology of Disease 20(3). p.744-751
- Contribution to journal › Article

« previous
1
…
9
10
11
12
13
next »